Skip to main content
Category

News

FACT SHEET: Five Things You Should Know About Kamala Harris and Health Care

The Biden-Harris administration has been instrumental in expanding access to quality health care for millions of Americans while also driving down health care costs. Whether it’s lowering the cost of drugs, capping the monthly cost of insulin, or making sure millions of Americans have access to affordable health insurance, this administration has fought for everyday Americans and won. Vice President Harris has battled for better health care her entire time in public office – as California’s Attorney General, as Senator, and as Vice President. At every level of government, Vice President Harris has been a champion for better and more affordable health care for every American.

Here are some of the highlights from her extensive track record on health care:

  1. Vice President Harris cast the tie-breaking vote which allowed the Inflation Reduction Act to pass the Senate and become law. As Vice President, Kamala Harris has cast the most tie-breaking votes in history including for the seminal pieces of legislation of the Biden-Harris administration, the American Rescue Plan and the Inflation Reduction Act. Now two years after the passage of the Inflation Reduction Act, around 19.7 million Americans are saving on average $700 a month on health insurance, nearly 82 million Americans have access to no-cost vaccines and preventive care through Medicaid and CHIP, 10 million seniors received free vaccinations in 2023 alone, and Medicare is currently negotiating the price of 10 drugs taken by over 9 million seniors. On top of this, the Inflation Reduction Act capped monthly insulin costs at $35 for 3.3 million seniors on Medicare Part D. Surveys show around 1.5 million seniors would have seen cumulative savings of about $734 million in Part D and $27 million in Part B if this cap were in effect in 2020. Without her deciding vote, millions of Americans would be paying more for health care, with some not having any access at all. Now Vice President Harris is fighting to expand the savings from provisions like the $35 insulin cap to all Americans, including those with private coverage. 
  2. Kamala Harris filed 10 amicus briefs defending the Affordable Care Act as California Attorney General, and as Senator co-sponsored 14 pieces of legislation protecting and expanding on the ACA, including legislation expanding preventive care requirements for private and public health insurance. Kamala Harris has a long and consistent history of fighting to defend and expand the ACA. Whether she was defending the constitutionality of the ACA in court, to arguing for the protection of contraception mandates, to ensuring that Republican plans to flood the ACA marketplace with junk plans could not come to fruition, at every turn Harris has stood up for the American people against interest groups wanting to increase their health care costs. Her history on health care is clear, Kamala Harris wants Americans to have lower costs and better care. 
  3. Kamala Harris has always fought for reproductive freedom. During her time in the Senate, Kamala Harris co-sponsored 14 pieces of legislation that would expand and protect the reproductive rights of Americans. From supporting the Women’s Health Protection Act to protecting access to birth control to fighting for the expansion and protection of insurance coverage for abortions, Kamala Harris has a remarkably consistent record when it comes to ensuring Americans have access to quality and affordable reproductive health care. She has fought against the GOP war on reproductive rights since she was California’s AG filing amicus briefs arguing against the dystopian restrictions on abortion access in states like Texas and helping the California Congress create legislation ensuring equal access to reproductive health services to all people within the state. As Vice President, Harris has been a leader standing up for reproductive freedom working to protect access to abortion care and affordable high-quality contraception. 
  4. Kamala Harris has prioritized maternal health and increasing health care equity. Maternal mortality in the U.S. is highest in the industrialized world, with around one-third of maternal deaths occurring during the postpartum period. Studies show that at least a factor of the incredibly high rate of perinatal maternal mortality is due to coverage disruptions during the first year after pregnancy, something which disproportionately affects people of color. As Vice President, Harris has challenged states to extend postpartum Medicaid coverage from only two months to a full year. This policy would allow for over 720,000 people annually to see expanded coverage who wouldn’t have been able to access it otherwise. Now, thanks to these efforts, 46 states and Washington DC have adopted full extended postpartum coverage.Black women are three times more likely to die from pregnancy-related complications than white women in the United States and maternal mortality rates — already higher than any other developed country — are still dramatically increasing. Even so, an estimated 80 percent of these deaths are preventable, making the passage of legislation addressing this crisis even more critical. As a Senator, Kamala Harris was involved with creation and proposing of the first Black Maternal Health Momnibus Act to address this crisis in maternal health. The “Momnibus” would direct HHS to establish task forces to address social determinants of health and award grants to innovations in maternity care and maternal mortality tracking. It also would expand federal nutrition programs through increasing the postpartum and breastfeeding periods and reduce specific state funding to jurisdictions which have no laws restricting constraints on incarcerated pregnant people. Every year since 2020, the Momnibus Act has been reintroduced in the Senate. It is perhaps the most essential central piece of legislation existing to address maternal mortality rates and health equity.
  5. As the California Attorney General, Kamala Harris was a part of cases which fined pharmaceutical companies nearly $7.2 billion for deceptive marketing, inflating prices, and harming American consumers. Then-Attorney General Harris broke records throughout her term when it came to settlements holding pharmaceutical companies accountable for deceptive and illegal practices. She was involved in the second largest recovery from a pharmaceutical company and the largest consumer protection settlement reached with a pharmaceutical company. Of the billions she was able to recover due to inflated drug prices and illegal marketing practices, $2.2 billion came from Johnson and Johnson, whose drugs Xarelto, Stelara, Imbruvica are currently up for Medicare price negotiation, $71 million came from Amgen, whose drug Enbrel is currently up for Medicare price negotiation, $68.5 million came from AstraZeneca, whose drug Farxiga is currently up for Medicare price negotiation, and $19.5 million came from Bristol-Myers Squibb, whose drug Eliquis is currently up for Medicare price negotiation.

NEW REPORT: GREED WATCH: Big Drug Companies Continue to Put Profits Over People

Big Drug Companies Raked in $22.3 Billion in Profits in the Second Quarter of 2024, Spent Nearly $27 Million on Lobbying, and Spent $62 Billion On Stock Buybacks and Dividends In The First Half of 2024

Big drug companies have raked in eye-popping revenues this year. 14 of the biggest drug companies reported $184.2 billion in revenue between April and June, and over $22 billion in net profits, reflecting the record-high prices these companies charge for drugs.

Drug companies have been allowed to charge whatever they want for too long. They make billions while charging Americans prices up to eight times higher than in other high-income countries like Germany or Australia, forcing patients to cut pills and skip doses to make ends meet. Fortunately, the Biden-Harris administration and Democrats in Congress passed the Inflation Reduction Act, lowering drug costs for people on Medicare by finally giving Medicare the power to negotiate lower drug prices.

Drug companies are also rewarding their shareholders handsomely rather than making their products more affordable to patients. The fourteen companies have spent hundreds of millions or billions on dividends and stock buybacks this year so far. Additionally, Bristol Myers Squibb, Novartis, and Novo Nordisk spent more lining the pockets of shareholders than on their research and development budgets. Research shows that pharmaceutical manufacturers could lose $1 trillion in revenue over a decade and still be the most profitable industry.

Table 1: Q2 2024 Big Drug Company Revenue, Profits, and Spending

Drug Manufacturer Quarterly Revenue H1 Shareholder Compensation Quarterly Research & Development Spending Quarterly Net Profits
Johnson & Johnson $22.4 billion $4.5 billion $3.4 billion $4.7 billion
Rochea $17.2 billion $11.3 billion $8.2 billion (H1)**** $7.4 billion (H1)****
Merck $16.1 billion $2.4 billion $3.5 billion $5.5 billion
Pfizer $13.3 billion $4.8 billion* $2.7 billion $41 million
AstraZeneca $12.9 billion $3.0 billion* $3.0 billion $1.9 billion
AbbVie $14.5 billion $1.3 billion** $1.9 billion $1.4 billion
Bristol Myers Squibb $12.2 billion $5.0 billion** $2.9 billion $1.7 billion
Novartis $12.5 billion $11.3 billion $2.4 billion $3.2 billion
Sanofib $11.7 billion $5.4 billion $1.7 billion $1.1 billion
Novo Nordiskc $9.8 billion $7.0 billion $2.3 billion $2.9 billion
GSKd $10.0 billion $2.3 billion* $1.9 billion $1.7 billion
Eli Lilly $11.3 billion $1.1 billion* $2.7 billion $3.0 billion
Amgen $8.4 billion $2.4 billion* $1.4 billion $746 million
Bayer $11.9 billion $123.5 million* $1.6 billion N/A
Total $184.2 billion $62.0 billion $28.2 billione $22.3 billione
* dividends only
** share repurchases only
*** unreported or net loss
**** data not reported on a quarterly basis
a CHF converted to USD based on the average quarterly exchange rate of 0.90 CHF to $1.00
b EUR converted to USD based on the average quarterly exchange rate of €0.935 to $1.00
c DKK converted to USD based on the average quarterly exchange rate of 6.971 kr. to $1.00
d GBP converted to USD based on the average quarterly exchange rate of £0.791 to $1.00
Roche H1 numbers included in quarterly total, since Q1/Q2 numbers are unavailable

Big Drug Companies Remain Highly Profitable & Expanded Investment Activity This Quarter, Countering the False Claims that Medicare Negotiation Undermines Innovation.

In the year following the passage of the Inflation Reduction Act, drug companies increased investment in bringing new drugs to market through higher spending on research, development, and acquisitions. In fact, following the passage of the Inflation Reduction Act, investment in research and development spending reached $161 billion in 2023, a 16.6 percent increase over 2022 and a nearly 50 percent increase since 2018. And despite the big drug companies arguing that the new law disincentivizes investment in small molecule drugs, a recent investor report confirms that the opposite is true. 

Big drug companies continue to harp on the Inflation Reduction Act, pushing lawsuits to halt Medicare Negotiation and claiming it hurts innovation – all while touting innovative new drug portfolios to Wall Street:

  • Johnson & Johnson CEO Joaquin Duato touted his company’s “relentless focus on advancing the next wave of medical innovation” and admitted that he anticipated his business “growing 3% plus next year and then 5% to 7% out through 2030” – despite Medicare Negotiation impacting three separate drugs manufactured by Johnson & Johnson. The company also spent approximately $17 billion purchasing new products for its pipeline in the first six months of 2024.
  • AstraZeneca executive Dave Frederickson admitted, “I think that IRA represents a couple of headwinds that we’ve spoken through, I think that they’re manageable, and I think we’ve got a portfolio that allows us to grow through it” – despite suing to overturn the Negotiation Program so they can continue to charge whatever they want for their drugs. The company also spent $2.4 billion to acquire Fusion Pharmaceuticals, Inc. in June 2024 and over $1 billion to acquire Amolyt Pharma in July 2024.
  • Merck CEO Robert Davis bragged about “the growing breadth of our pipeline,” noting, “We have the potential to bring as many new drugs to market in the next five years, as we launched over the next ten years, across a greater number of therapeutic areas and modalities and with a significant proportion having blockbuster-plus potential” – all despite suing the federal government to halt Medicare Negotiation. The company also acquired two additional companies for a combined $2.6 billion in 2024.
  • Eli Lilly CEO David A. Ricks attributed massive quarterly revenue growth of 36 percent year-over-year in part to the continued success of Jardiance, a drug whose list price has doubled since it launched over a decade ago. Ricks serves on the board of directors for pharmaceutical trade group PhRMA, which is suing to block Medicare Negotiation so drug companies can continue charging whatever they want for drugs. The company also announced an agreement to acquire Morphic for approximately $3.2 billion this quarter.

The Companies Manufacturing Drugs Being Negotiated By Medicare Brought In Billions in Revenue and Profits from Taxpayers and Patients and Spent It Lavishly To Reward Shareholders.

This quarter, the ten drugs selected for Medicare’s first round of negotiations brought in $18.1 billion in revenue, while the companies that manufacture these drugs raked in $16.2 billion in combined profits and spent nearly $25 billion rewarding shareholders in the form of stock buybacks and dividends:

  • Amgen, the manufacturer of Enbrel, reported $8.4 billion in revenue and spent $1.2 billion on dividends for investors. Amgen has increased the price of Enbrel by 701 percent since it launched.
  • AstraZeneca, the manufacturer of Farxiga, reported $12.9 billion in revenue and $1.9 billion in net profits. AstraZeneca has increased the price of Farxiga by nearly 87 percent since it launched.
  • Bristol Myers Squibb, which jointly manufactures Eliquis with Pfizer, raked in $1.7 billion in profits this quarter. Bristol Myers Squibb and Pfizer have increased the price of Eliquis by 124 percent since it launched.
  • Johnson & Johnson, which manufactures three of the ten drugs with lower prices being negotiated – Xarelto, Stelara, and Imbruvica – made $22.4 billion in revenue and $4.7 billion in net profits, while spending $136 million on stock buybacks. Johnson & Johnson has increased the price of Stelara by nearly 185 percent since it launched.
  • Merck, which manufactures Januvia, raked in $16.1 billion in revenue and $5.5 billion in net profits and spent more than $251 million on shareholder compensation. Merck has increased the price of Januvia by 293 percent since it launched.
  • Novartis, which manufactures Entresto, reported $12.5 billion in revenue and $3.2 billion in net profits while spending $11.3 billion on investors. Novartis has increased the price of Entresto by 83 percent since it launched.
  • Novo Nordisk, the manufacturer of Fiasp/NovoLog, far exceeded even their earnings expectations, bringing in $9.8 billion in revenue and $2.9 billion in net profits while spending $2.5 billion on shareholder compensation. Novo Nordisk has increased the price of the drug by 82 percent since it launched.
  • AbbVie, which jointly markets Imbruvica with Johnson & Johnson, brought in $14.5 billion in revenue and $1.4  billion in net profits this quarter. AbbVie and Johnson & Johnson have increased the price of the drug by 114 percent since it launched.
  • Eli Lilly, which jointly markets Jardiance with privately-held Boehringer Ingelheim, brought in $11.3 billion in revenue and $3.0 billion in net profits while rewarding shareholders with over $1 billion in dividends. Eli Lilly and Boehringer Ingelheim have increased the price of the drug by 103 percent since it launched.
  • Pfizer, which jointly markets Eliquis with Bristol Myers Squibb, brought in $13.3 billion in revenue and $41 million in net profits and spent $2.4 billion rewarding shareholders with dividend payments.

Table 2: Q2 2024 Revenue For Drugs Selected For Medicare Negotiation

Selected Drug Manufacturer Condition(s) Treated Quarterly Revenue Total Revenue Since Launch
Eliquis Bristol Myers Squibb, Pfizer Blood clots $5.3 billion $117.3 billion
Stelara Johnson & Johnson Psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis $2.9 billion $69.7 billion
Entresto Novartis Heart failure $1.9 billion $24 billion
Farxiga AstraZeneca Diabetes, Heart failure, and Chronic kidney disease $1.9 billion $24.7 billion
Imbruvica AbbVie, Johnson & Johnson Blood cancers $1.6 billion $61.7 billion
Jardiance Eli Lilly Type 2 diabetes $768.6 million* $11.2 billion*
Fiasp/NovoLog Novo Nordisk Diabetes $554.9 million $45 billion
Enbrel Amgen Rheumatoid arthritis, Psoriasis, and Psoriatic arthritis $909 million $85.8 billion
Xarelto Johnson & Johnson, Bayer Blood clots $1.5 billion $68.6 billion
Januvia Merck Type 2 diabetes $629 million $54.3 billion
Totals  $18.1 billion $562.3 billion
*Revenue for Jardiance, which is co-manufactured by Boehringer Ingelheim, only includes Eli Lilly.

Big Drug Companies Are Suing to Block Medicare from Negotiating Lower Prices and Spending Millions On Lobbying. 

Big drug companies are suing to ban Medicare from negotiating lower prescription drug prices for millions of Americans. If they get their way, patients will pay more so the drug companies can make more money. Seven big drug companies have filed separate lawsuits against the federal government to overturn the Inflation Reduction Act, and multiple lobbying groups representing big drug companies have also filed lawsuits. These lawsuits have already faced serious setbacks; drug companies are zero for six in the courts. This quarter alone, a New Jersey district court rejected Novo Nordisk’s case, and a federal judge in Connecticut rejected Jardiance co-manufacturer Boehringer Ingelheim’s case.

Meanwhile, these same drug companies and their allies are spending millions of dollars lobbying Congress to protect their profits. 16 of the biggest drug companies spent $26.8 million this quarter on lobbying. Big drug companies have already been increasing their lobbying efforts dramatically, this year with industry group PhRMA’s advocacy spending growing 20 percent last quarter compared to 2024.

Table 3: Big Drug Companies Spent Nearly $27 Million On Lobbying In Q2 2024

Manufacturer Selected Drug Quarterly Lobbying Spending
Merck Januvia $3.1 million
Amgen Enbrel $2.7 million
Eli Lilly Jardiance $2.6 million
Pfizer Eliquis $2.5 million
Bayer Xarelto $2.2 million
Roche N/A $2.0 million
GSK N/A $1.5 million
Gilead N/A $1.5 million
Johnson & Johnson Imbruvica, Stelara, Xarelto $1.3 million
Novo Nordisk Fiasp/NovoLog $1.2 million
Novartis Entresto $1.1 million
AstraZeneca Farxiga $1.1 million
Boehringer Ingelheim Jardiance $1.0 million
Sanofi (US) N/A $860,000
Astellas (US) N/A $770,000
Bristol Myers Squibb Eliquis $740,000
AbbVie Imbruvica $580,000
Total $26.8 million

 

Minnesota Governor Tim Walz Is A Health Care Champion

Minnesota Governor Tim Walz is a health care champion with a demonstrated record of fighting to ensure that his constituents have access to affordable, high-quality health care. While in Congress he helped pass the Affordable Care Act and has since worked to safeguard and build on its success. Walz has fought to protect Medicaid and Medicare, lower prescription drug costs, and protect access to reproductive health care.

“Governor Tim Walz is a health care champion,” said Protect Our Care Chair Leslie Dach. “During his time in Congress, Walz played a key role in passing the Affordable Care Act, and he worked to defend the law from Donald Trump’s repeal efforts. As Governor he continues to increase coverage, fight for lower health care costs and is a loud and effective voice on reproductive freedom.”

Passed, Safeguarded, and Built On The Affordable Care Act

Governor Tim Walz Oversaw Record Affordable Care Act Marketplace Enrollment. Walz has built on the Affordable Care Act, ensuring that eligible Minnesotans can enroll in affordable health care coverage offered through the state’s ACA Marketplace. Under his leadership, Walz oversaw record enrollment in ACA Marketplace coverage. More than 146,000 Minnesotans purchased coverage on the Minnesota ACA Marketplace for 2024 – an increase of 13 percent over 2023 – with 60 percent of people enrolled saving an average of $6,460 per year on health insurance premiums thanks to premium tax credits.

2017: While Serving In Congress, Tim Walz Helped Kill Trump’s Affordable Care Act Repeal. Tim Walz represented Minnesota’s southernmost 1st Congressional district from 2007 to 2019. While serving in the House of Representatives, Walz voted against the passage of Trump’s American Health Care Act (AHCA), which would have repealed the Affordable Care Act and replaced it with a much worse law. Approximately 1 in 2 people in America with pre-existing conditions would have lost protections for coverage and 23 million people would have lost coverage under this bill by 2026. The nonpartisan Congressional Budget Office found that the AHCA would have raised premiums by 20 percent. The negative economic impact of the AHCA would have caused 1.8 million people to lose their jobs by 2022.

2015: Tim Walz Helped Prevent A Total Repeal Of The Affordable Care Act. Walz voted against HR 596, an act “to repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010.” The bill also ordered House committees to develop a replacement that would “provide people with pre-existing conditions access to affordable health coverage,” but provided no specifics. 

2010: Tim Walz Helped Pass The Affordable Care Act. While serving in Congress, Walz voted for HR 3590, also known as the Patient Protection and Affordable Care Act (ACA), in March 2010.

Thanks to Walz and Democrats in Congress:

  • GAINED: Protections for more than 100 million Americans with pre-existing conditions.
  • GAINED: Medicaid expansion, which covers about 24 million people. 
  • GAINED: Quality, affordable coverage for over 21.3 million people who buy insurance on their own.
  • GAINED: 2.3 million adult children are able to stay on their parents’ insurance. 
  • GAINED: Ban on insurance companies charging women more than men.
  • GAINED: Ban on insurance companies having annual and lifetime caps on coverage.
  • GAINED: Requirements that insurance companies cover prescription drugs and maternity care.
  • GAINED: Premium tax credits that make premiums affordable for 80 percent of people who purchase health care on the Marketplace.
  • GAINED: Closing the Medicare ‘donut hole,’ which helps around 52 million seniors pay less for prescription drugs.
  • GAINED: Critical funding for rural hospitals. 
  • GAINED: Policies that help around 67 million people on Medicare have lower costs and better medical care.

Protecting Medicare & Medicaid

Governor Walz Has Fought To Preserve The Health Care Access Fund. While serving as Governor, Walz has fought to preserve the Health Care Access Fund, which 1.2 million Minnesotans rely upon for health care access.

2017: While Serving In Congress, Tim Walz Helped Kill Trump’s ACA Repeal, Which Would Have Cut $880 Billion From Medicaid. Walz voted against Trump’s ACA repeal, which included $880 billion in cuts to Medicaid. Vox called Trump’s ACA repeal bill a “sneaky” reversal of Medicaid expansion, writing, “The AHCA reverses this expansion. But to avoid the criticism that the law throws poor children off their health insurance, it reverses it in a somewhat sneaky way. Rather than taking Medicaid away from families who have it, it simply caps new enrollments in Medicaid so no new poor families can sign up.

Lowering Costs and Improving Care

Governor Walz Has Fought To Lower Prescription Drug Costs For Minnesotans. While serving as Minnesota Governor, Walz has championed legislation to increase transparency in prescription drug costs. He also signed the Alec Smith Insulin Affordability Act to provide relief to Minnesotans struggling to afford their insulin.

Under Governor Walz, Minnesota Has Been Named The Best State For Health Care. Minnesota has been named the best state for health care for two consecutive years under Walz’s leadership.

Governor Walz Has Worked To Improve Long-Term Care. Last year, Walz signed a bill increasing protections for seniors in assisted living facilities. The bill requires facilities to an assisted living bill of rights, including minimum staffing requirements, training requirements, and eviction protections.

Fighting To Protect Reproductive Health Care

Governor Walz Has Fought To Protect People Seeking Reproductive Health Care In Minnesota. Earlier this year, Walz issued an executive order declining to extradite people who are charged under other states’ laws that criminalize providing, seeking, or obtaining an abortion. He declared, “As long as we occupy this office, access to abortion services and reproductive care will be safe, legal, accessible and as affordable as we can make it.”

Polling Shows That Health Care Remains A Top Priority for Americans

Polling throughout 2024 shows that health care is a core voting and economic issue for the American people headed into November. In every election since 2018, voters have gone to the polls and voted for better health care and lower costs, and this election is no different. Health care is a kitchen table issue that receives strong support from a majority of voters, whether they live in red or blue states, or rural, suburban, or urban zip codes. Health care is also a powerful emotional issue –  as we all know when we or a family member gets sick, it takes over our lives and, when you can’t afford the care you need, it is devastating.

The Biden-Harris administration and Democrats in Congress have fought tirelessly to lower costs for working people, middle-class families, and seniors. The Inflation Reduction Act’s health care savings are widely popular, and voters support Democrats’ plans to build on these health care victories to extend lower prescription drug prices to everyone. 

While Democrats lower costs for people, Republicans are fighting on behalf of big drug companies to ban Medicare from negotiating lower drug prices and repeal the Affordable Care Act, which would take away health care from millions of Americans, block coverage for people with pre-existing conditions, and drive up costs for millions more. In stark contrast to Democrats’ health care policies, these Republican priorities are unpopular across the board. 

June 2024 Hart Research And Protect Our Care Poll Finds That Democrats’ Health Care Agenda Is A Powerful Issue For Voters.

  • Popularity Of The Affordable Care Act (ACA) Is At An All Time High. Over 60 percent of voters view the law as favorable. 17 percent of Trump voters and 21 percent of Congressional Republican voters also favor the ACA and disagree with the GOP plan to repeal the ACA. Voters are particularly worried about getting rid of pre-existing condition coverage and no-cost preventive care, as well as kicking young adults off of parents’ insurance. There is also broad support (82% favor, 47% strongly favor) for permanently lowering the cost of premiums for people who buy insurance through the ACA.
  • Drug Pricing Reforms Made Possible By The Inflation Reduction Act Are Extremely Popular. Legislation to expand drug cost reduction including expanding Medicare’s power to negotiate lower drug prices, applying the $2,000 out-of-pocket cost cap to people with private insurance as well as people on Medicare, and capping the cost of insulin and inhalers for all Americans is supported by 84 percent of voters.
  • Voters Are Less Likely To Vote For The Candidate Who Will Cut Medicare And Medicaid. 68 percent of voters would be less likely to vote for a Republican candidate who voted to cut tens of billions of dollars in funding for Medicare. Voters also have a favorable opinion of Medicaid – 77 percent – and over 60 percent of voters say they would be less likely to vote for a Republican who supports large Medicaid cuts.
  • Health Care Is An Election Winning Issue. This Hart Research poll found that health care is an election winning issue and there is power in contrasting Republicans’ opposition of lowering drug costs and making health care more accessible and affordable with their plans to give tax breaks to the big and wealthy corporations. 80 percent of voters say that health care will be fairly or very important to them when voting this November.

May 2024 Pew Research Poll Shows That Health Care Is A Top Issue Heading Into November.

  • Health Care Affordability Is A ‘Very Big Problem’ For Americans. A May 2024 poll by Pew Research found that health care was the third highest priority for voters with a total of 89 percent of respondents saying that affordability of health care was either a ‘very big problem’ or ‘moderately big problem’ for the country.

June 2024 Navigator Poll Finds That Americans In Battleground States View Medicare Drug Negotiation And Insulin Price Caps As The Most Impactful Policies and Are Highly Supported.

  • Medicare Price Negotiation And Insulin Cost Cap Is Popular Despite Party Affiliation. Medicare’s ability to negotiate drug costs and capping the cost of insulin to $35 monthly for seniors are strongly supported by 62 percent of Americans in battleground states, regardless of party affiliation. This policy is also viewed as one of the most personally impactful policies by these Americans.
  • Bringing Down Health Care Costs Resonates Most With Voters. Policies that bring down costs resonate the most with Americans in battleground states. 51 percent of constituents say that policies driving down the cost of health care will help improve their lives the most.

July 2024 Navigator Poll Finds That American Do Not Support Republicans’ Project 2025 Health Care Policies.

  • Americans Agree Removing Pre-Existing Coverage Protections Is A Bad Idea. 82 percent of Americans view removing pre-existing protections as a harmful policy of Project 2025. This is one of the most harmful policies in Project 2025 according to those identifying as non-MAGA Republicans.
  • Project 2025’s Plan To Get Rid Of Drug Pricing Measures Is Not Supported. 79 percent of Americans disagree with Project 2025’s proposal to ban Medicare from negotiating for lower prescription drug costs and eliminate the $35 monthly cap on the price of insulin for seniors. 

May 2024 KFF Poll Finds That A Majority Supports Extending Savings From Democrat Health Care Policies.

  • Americans Across Partisan Lines Support Extending Medicare Drug Pricing Provisions. 86 percent of voters, including 89 percent of Republicans, support capping monthly out-of-pocket costs for insulin for all adults with health insurance. In addition, 84 percent of voters, including 87 percent of Republicans, support placing a limit on out-of-pocket prescription drug costs for all adults with health insurance.
  • Majority Support Increasing Number of Drugs Subject to Price Negotiation Under Medicare. 75 percent of voters, including 68 percent of Republicans, support expanding the number of drugs subject to price negotiation under the Inflation Reduction Act.
  • Americans Across Partisan Lines Support Extending Premium Subsidies For Those Insured Through The Marketplace. 60 percent of voters have a favorable view of the ACA with support continuing to be split along partisan lines. However, there is significant support for the Democrats’ position on extending tax subsidies for people who purchase coverage through the Marketplace. 73 percent of Independents and 57 percent of Republicans support extending subsidies.

Project 2025 Aims to Raise Costs and Throw Our Health Care System Into Chaos

With Donald Trump as the official GOP presidential nominee, health care is once again on the chopping block. Donald Trump has renewed calls to “terminate” the Affordable Care Act (ACA).  MAGA allies at the Heritage Foundation released Project 2025, a dangerous policy roadmap designed to give more tax breaks to big corporations and the wealthiest Americans by decimating the middle class and stripping away our health care. The GOP plan for health care is clear: repeal the Inflation Reduction Act and ACA, slash Medicaid and Medicare funding, repeal protections for pre-existing conditions, raise prescription drug and premium costs, and strip away health care from millions of Americans all while giving tax breaks to billionaires, CEOs, and corporations. If Trump and MAGA Republicans get their way, it would be disastrous for tens of millions across the nation. Here is a quick look at the health care policies proposed in Project 2025:

Hike Health Care Costs and Rip Away Protections For Pre-Existing Conditions

Project 2025 calls for repealing the Inflation Reduction Act. This means it would end enhanced premium tax credits that lower insurance costs for Americans purchasing coverage on their own through the ACA. Getting rid of these premium tax credits would make health care more expensive, threatening coverage and well being for millions of Americans. 

In addition, a core piece of the Project 2025 plan would codify rules put forth by the Trump administration that expanded junk health insurance plans known as association health plans. These plans charge people who have pre-existing conditions more and deny coverage for essential services like prescription drugs and maternity care, leaving people with unexpected medical bills. 

If Project 2025’s proposals are enacted:

  • GONE: Lower health care premiums for the over 20 million who buy their own coverage through the Marketplace. Ending the tax credits would mean a typical 60-year-old couple making $80,000 per year would see their premiums triple to over $24,000 per year and premiums for a family of four making $125,000 would increase by $7,676.
  • GONE: Protections against catastrophic surprise hospital bills through total repeal of the No Surprises Act. Nearly 9 million people avoided surprise bills in 2022 alone. 
  • GONE: The Medicaid Drug Rebate Program which gives low income Americans lower costs and allows states to expand drug coverage while maintaining savings. 

Increase Prescription Drug Costs

Project 2025’s plan to fully repeal the Inflation Reduction Act would eliminate the lifesaving insulin cost cap and Medicare’s power to negotiate lower drug prices. As a result, health care costs will skyrocket for families while drug and insurance companies and their CEOs are allowed to charge Americans whatever they want and get billions in tax breaks. 

If Project 2025’s proposals are enacted:

  • GONE: $35 cap on monthly insulin costs for people with Medicare 
  • GONE: Medicare’s power to negotiate lower prices for the most popular and expensive prescription drugs. Nearly 9 million people take the first ten drugs that were selected for Medicare negotiation, which account for 20 percent of Medicare Part D yearly spending. 
  • GONE: Prescription drug savings for people on Medicare, including a new $2,000 annual out-of-pocket cap and protections from drug company price hikes through inflation rebates. Nearly 19 million American seniors are expected to save an average of $400 per year.
  • GONE: Free vaccines for 52 million people on Medicare, including for shingles and pneumonia. 
  • GONE: Prescription drug savings for 4 million low-income seniors through the Medicare Part D Extra Help program.

Changing and Cutting Medicare

Project 2025 proposes stripping Medicare coverage from seniors, increasing prescription drug prices, increasing fraud throughout the system, and forcing seniors to pay more for their health care. This plan puts essential coverage for our nation’s seniors in jeopardy.

If Project 2025’s proposals are enacted:

  • GONE: The Medicare Shared Savings Program which saves CMS over $2.5 billion annually and impacts nearly 11 million people with Medicare.
  • GONE: Rural hospitals as Medicare Advantage plans continue to systemically underpay rural providers and deny coverage to rural Americans.
  • GONE: Medicare’s inflation rebate which has lowered costs for 203 drugs, 64 of which just this past quarter were subject to the rebate, used by around hundreds of thousands of Medicare beneficiaries annually since the program began.
  • GONE: The Medicare plans for 33 million seniors who would be forced over into a Medicare Advantage plan.

Slashing Medicaid

Project 2025 repeatedly refers to Medicaid and its expansion under the ACA to low-income adults as “failing” and too expensive to maintain. Project 2025 proposes overhauling Medicaid expansion and imposing onerous work requirements, time limits, and lifetime caps, eliminating mandatory benefits, and funneling Medicaid funding toward vouchers for private insurance, whose plans will be far less affordable and provide fewer benefits. Their plan for Medicaid is simple: throw people off of their coverage and raise health care costs across the board. 

If Project 2025’s proposals are enacted:

  • GONE: Coverage for 21 million people because of the GOP’s onerous work reporting requirements. 
  • GONE: Protections and health care for up to half of the 38 million children currently covered through Medicaid and CHIP.
  • GONE: Essential federal funding for states like Mississippi, whose population makes less than the federal average income, to support their Medicaid programs so that working-class Americans can continue to receive quality and affordable health care.
  • GONE: Federal funding for Medicaid expansion, putting coverage for about 24 million Americans at risk. 
  • GONE: Billions in state funding for Medicaid, as Republicans plan to eliminate provider taxes to cut taxes for the rich at the expense of Americans’ health care.

Restricting Reproductive Rights

Project 2025 calls for a national abortion ban and a reverse of the FDA’s approval of Mifepristone; the safe, effective, and most common medication prescribed for an abortion regimen. Project 2025 would also limit access to contraception and IVF for millions of Americans.

If Project 2025’s proposals are enacted:

  • GONE: Access to abortion care if a state wants to maintain federal funding for its Medicaid programs.
  • GONE: The ACA’s requirements that employers cover contraceptives, potentially increasing a woman’s out-of-pocket costs for contraception by more than $584 annually.
  • GONE: The ability to seek a life-saving abortion at a Medicare-funded hospital as doctors could face up to 5 years in prison.
  • GONE: All funding to Planned Parenthood which in just 2023 had over 2 million patients and performed nearly 10 million services including cancer screenings, STI tests, etc.
  • GONE: No-cost emergency contraception currently available to 47.8 million Americans.

59 Years Later: Medicare and Medicaid Are Under Attack As Republicans Wage War on Health Care

Washington, DC — On this day, 59 years ago, President Lyndon B. Johnson signed Medicare and Medicaid into law, improving the well-being of millions of Americans and saving countless lives along the way. While the Biden-Harris administration and Democrats in Congress have delivered lower health care costs and strengthened Medicare through the Inflation Reduction Act, MAGA Republicans continue to escalate their war on American health care. They released Project 2025, a dangerous policy roadmap designed to give more tax breaks to big corporations and the wealthiest Americans by decimating the middle class and stripping away our health care. 

Project 2025 would fully repeal the Inflation Reduction Act – including its lifesaving insulin cost cap and the power for Medicare to negotiate lower drug prices. Project 2025 also proposes overhauling Medicaid expansion and imposing onerous work requirements, time limits, and lifetime caps, eliminating mandatory benefits, and funneling Medicaid funding toward vouchers for private insurance, whose plans are far less affordable while providing fewer benefits. As a result, millions of people would lose their health care and costs would go up across the board. 

To mark the anniversary, Protect Our Care Chair Leslie Dach issued the following statement:

“Nothing better exemplifies the GOP war on health care than their relentless attacks on Medicare and Medicaid. MAGA Republicans have laid bare their plans for American health care: they are going to fight tooth and nail to reverse all of the progress made by Democrats and the Biden-Harris administration, raise costs, deny coverage to millions of people, and slash funding for these critical programs. The Republican position on Medicare and Medicaid is clear – cut it all and let American families suffer the consequences. As a result, families will lose the care they need to stay healthy, the ability to age with dignity, and control over their financial future. There could not be more at stake.”

Background: 

FACT SHEET: Trump and MAGA Republicans’ Vision To Slash Medicare and Medicaid

Hiking Costs for Seniors

While President Biden and Democrats delivered lower prices, Trump wants to put drug companies back in charge and slash tens of billions from Medicare in order to pay for tax breaks for the wealthy. The MAGA GOP plan hikes costs on premiums and prescription drug costs for seniors. Trump and his MAGA allies’ plan, Project 2025, would fully repeal the Inflation Reduction Act – including its prescription drug provisions like capping insulin costs and lowering drug prices for seniors. They also want to ban Medicare from being able to negotiate lower prices for prescription drugs, allowing drug companies to charge as much as they want. Worst of all, Trump wants to slash tens of billions from Medicare in order to pay for tax breaks for the wealthy, deregulating the program and pushing seniors towards private plans with limited coverage networks. 

If Trump and His MAGA Allies Got Their Way:

  • GONE: Tens of billions in Medicare funding to pay for tax breaks for the wealthy.
  • GONE: Medicare’s power to negotiate lower prices for the most popular and expensive prescription drugs.
  • GONE: People on Medicare’s prescription drug savings, including a $2,000 annual out-of-pocket cap and protections from Big Pharma’s price gouges. Nearly 19 million American seniors are expected to save an average of $400 per year.
  • GONE: Protections for people on Medicare from drug company price hikes through inflation rebates.
  • GONE: Free vaccines for people on Medicare, including for shingles and pneumonia. 
  • GONE: $35 monthly insulin cap for 4 million people on Medicare.
  • GONE: Expanded eligibility for Medicare’s Extra Help program, putting affordable prescription drug coverage further out of reach for millions of seniors.

Kicking Millions of Seniors, Children, and Low-Income Workers Off Medicaid

MAGA Republicans in Congress and Donald Trump are fully committed to their plan to slash Medicaid funding and rip away care from millions. One in four Americans count on Medicaid for access to health care, and the program serves people from all backgrounds, including children, mothers, people of color, working families, people with disabilities, rural Americans, and seniors. 

During his first term, Donald Trump waged war on Medicaid. Trump-era Medicaid policies included failed paperwork requirements for people who count on Medicaid, and proposing to arbitrarily change the poverty line to throw more people off of coverage. Project 2025 calls for radically restructuring Medicaid, cutting funding by over 50 percent long-term. Project 2025 proposes to kick people off Medicaid by tying Medicaid funding to state abortion bans, imposing onerous work requirements, and allowing states to redirect Medicaid funding toward private insurance.

Other GOP proposals, such as the Republican Study Committee budget, proposes cutting Medicaid spending by over 54 percent in the next decade and ripping coverage away from tens of millions of children, seniors, and people with disabilities. House Republicans have also introduced multiple pieces of legislation over the past year that would deny Medicaid coverage to certain low-income working adults if they do not meet strict work reporting requirements riddled with paperwork and faulty websites, a move that could rip coverage away from as many as tens of million people. The Republican position on Medicaid is clear: cut it all and let Americans suffer the consequences. 

The GOP Plan for Medicaid: 

  • GONE: Billions in state funding for Medicaid, cutting funding by over 50 percent long-term as Republicans plan to eliminate provider taxes in order to cut taxes for the rich at the expense of Americans’ health care.
  • GONE: Federal funding for Medicaid expansion, putting coverage for around 24 million Americans at risk. 
  • GONE: Coverage for 21 million people because of the GOP’s onerous work reporting requirements. 
  • GONE: Free recommended vaccines for people with Medicaid and CHIP coverage.
  • GONE: Protections and health care for up to half of the 38 million children currently covered through Medicaid/CHIP if Project 2025 plans are implemented
  • GONE: Essential federal funding for states like Mississippi, whose population makes less than the federal average income, to support their Medicaid programs so that working-class Americans can continue to receive quality and affordable health care.

Five Ways Trump and MAGA Republicans Are Threatening Access To Reproductive Health Care

Trump and MAGA Republicans Continue To Attack Reproductive Health Care Access As 22nd State Abortion Ban Takes Effect 

This week, Iowa became the 22nd state with an active abortion ban. Ever since the MAGA Trump-appointed Supreme Court overturned Roe v. Wade and ended nearly half a century of constitutionally protected abortion rights, attacks on reproductive health care from MAGA Republicans have skyrocketed, imperiling access to care for millions of Americans across the country. Donald Trump himself says that he is the one responsible for “killing Roe v. Wade.” He is responsible for the devastating consequences for women’s health and would push an extreme agenda taking away access to contraception and even in vitro fertilization (IVF). 

Just like Trump, Republicans have done nothing but push to limit access to essential reproductive care and they are pushing just as hard to limit access to contraception and IVF, pass a national abortion ban, undermine the Affordable Care Act, and gut Medicaid. Here are five ways Trump and MAGA Republicans are threatening reproductive care:

  1. Abortion Access Remains Under Threat. Two years ago, Donald Trump’s appointees to the Supreme Court overturned Roe v. Wade and the consequences for women’s health have been catastrophic, with cruel and archaic abortion bans spreading across the country. Since then, abortion extremists backed by Trump’s MAGA allies went to court to take the abortion medication mifepristone off the market entirely. At least 67 Republican members of Congress and 22 Republican attorneys general supported the push to ban mifepristone. Even though the MAGA SCOTUS just rejected their challenge, the case will return to the MAGA-packed Fifth Circuit Court of Appeals for further review. Republicans will not be deterred by the SCOTUS ruling, which rejected the challenge only on standing, paving the way for a future challenge to succeed on the merits of the case. If MAGA Republicans get their way there will be even more extreme judicial appointments and an all-out push to use the Comstock Act to create a de facto national ban on abortions and sharply limit access to medications.
    • State-Level MAGA Republicans Are Working To Punish Out-of-State Abortions. MAGA Republicans in states with draconian abortion bans have been finding ways to punish people seeking abortions out-of-state. Idaho passed a so-called “abortion trafficking” ban that was temporarily placed on hold by courts, and Alabama’s MAGA attorney general is attempting to use existing law to prosecute those who help others obtain abortions out-of-state. Texas Republicans are pushing for public lists of anyone pursuing an abortion as well as any family members who assisted or facilitated the effort.
  2. Republicans and Red State Judges Are Threatening Fertility Treatments Like IVF Through Extreme, Anti-Choice Policies. Earlier this year, the Alabama Supreme Court ruled that frozen embryos should be considered children, putting the future of in vitro fertilization (IVF) in jeopardy. Republicans have made it clear that they have no intention to protect reproductive health care in the post-Roe landscape, and Republicans in other states like Idaho are joining in, pushing anti-choice policies that create extreme uncertainty for reproductive health care access. Senate Republicans have moved to block legislation to protect IVF and other fertility treatments multiple times, with all but two Senate Republicans voting against codifying federal protections just last week.
  3. MAGA Republicans Are Targeting The Affordable Care Act, Which Provides Free Contraception. The Affordable Care Act’s contraception coverage requirement has drastically improved health care access and affordability for tens of millions of Americans. The benefits have reached far and wide — improving health outcomes and sharply cutting out-of-pocket costs. Despite the overwhelming success of the ACA’s contraception coverage, Republicans have attempted to eliminate this essential care year after year through legislation and litigation. Republicans have spent years taking dozens of failed votes to repeal the Affordable Care Act. They have also taken their fight to overturn the ACA to the Supreme Court and failed all three times. During his first term, Donald Trump notoriously tried and failed multiple times to repeal the ACA and throughout his 2024 campaign Trump has repeatedly reignited his calls to “terminate” the Affordable Care Act, which he claims is a “disaster.”Earlier this summer, the MAGA-dominated Fifth Circuit Court of Appeals also heard a challenge to a provision of the ACA that requires insurers to cover lifesaving preventive services for free. They ruled that the employers who brought the case do not have to cover these preventive services through their health plans, and sent back to the right-wing district court the questions of whether employers must continue to cover preventive services recommended by the Advisory Committee on Immunization Practices (ACIP) and Health Resources and Services Administration (HRSA). The decision leaves free preventive services at risk as the case proceeds through the legal system and opens the door to further litigation. By taking these actions, Republicans are fighting to strip protections that provide access to reproductive care.
    • The ACA Made Access To Birth Control Free For Over 60 Million Americans. The ACA guarantees that private health plans cover 18 methods of contraception and make them available to 58 million patients with no out-of-pocket costs. More than 99 percent of sexually active women have used contraceptives at some point in their lifetimes, and approximately 60 percent of women of reproductive age currently use at least one birth control method. In addition to increasing access to this essential treatment, this ACA provision has saved money for women and their families: women saved $1.4 billion on birth control pills alone in 2013.
    • The Trump Administration Already Made It Harder To Access Reproductive Health Care. The Trump administration took multiple steps to make it harder to access reproductive health care, including by allowing insurance providers to “opt out” of ACA-mandated coverage for contraception and barring federal funding for abortions. As President, Trump allowed more employers to opt out of birth control coverage in their workers’ health insurance. In August 2019, the Trump administration also began enforcing a rule that barred certain federally-funded clinics from referring women for abortions; as a result, the nation’s largest recipient of Title X funds, Planned Parenthood, was forced to exit the program, losing $60 million in funding previously used to provide birth control and reproductive health care services for low-income women.
    • Project 2025 Maps Out Broad Exemptions To ACA-Mandated Free Contraception. Project 2025 pushes for a set of “exemptions” to certain preventive care mandates for ACA-compliant coverage – including no-cost contraceptive coverage. This policy would reinstitute broad Trump-era exemptions that could increase every woman’s out-of-pocket costs for contraception by more than $584 annually while also allowing non-profit and for-profit employers to restrict their health coverage without notice.
  4. Trump And His Closest Allies Are Pushing To Restrict Access To Contraception. Trump and his MAGA allies are developing a blueprint for a second Trump administration to restrict birth control through a series of executive actions, and Trump recently said he was “looking at” imposing new policy restrictions on contraception. Project 2025 includes numerous proposals that would require coverage of so-called “natural planning” contraceptive strategies and remove requirements that insurance cover certain forms of emergency contraception.
  5. Republicans Are Waging a War on Medicaid, Which Covers Reproductive Health Care For Millions of Americans. Medicaid, which covers tens of millions of Americans, is an essential source of reproductive health care. Republicans in Congress and Donald Trump are itching for a renewed war on Medicaid. The latest proposals from the Republican Study Committee and the Trump team in-waiting at the Heritage Foundation, who authored Project 2025, would throw millions of people off their coverage through block granting and burdensome work reporting requirements. Almost two-thirds, or 62 percent, of those who would lose their Medicaid coverage as a result of work requirements, are women and disproportionately women of color.
    • Project 2025 Lays Out MAGA Plans To Tie Medicaid Funding to State Abortion Bans. Project 2025 would tie federal Medicaid funding to the adoption of new requirements for abortion surveillance. These new requirements would mandate that every state provides the CDC with the state of residence for any person seeking an abortion in the state, the medical reason for an abortion, the gestational age of a fetus, and the method of abortion.

Seven Years Ago Today, Donald Trump Failed To Repeal The Affordable Care Act But He’s Coming for it Again

Seven Years Since John McCain’s “Thumbs Down” Vote, The Affordable Care Act Is Still Under Attack By MAGA Republicans

Washington, D.C. — Seven years ago today, Senators John McCain, Lisa Murkowski, and Susan Collins joined Democrats, to block Donald Trump’s efforts to repeal the Affordable Care Act (ACA). To this day, Republicans haven’t given up on their war on health care and still want to destroy the ACA and all of its protections for over 100 million people with pre-existing conditions. Donald Trump sabotaged affordable health care and pre-existing condition protections while he was in office, and has renewed his call to terminate the ACA.

The ACA has survived countless repeal attempts, and now it’s stronger than ever. Thanks to the tireless work of President Biden, Vice President Harris, and Democrats in Congress, the 2024 open enrollment period was the most successful in history — a record-breaking 21.4 million Americans signed up for coverage. Coupled with the health law’s expansion of Medicaid, protections for people with pre-existing conditions, and cost-saving measures, the ACA has touched the lives of nearly every person in the nation.

In response, Protect Our Care Executive Director Brad Woodhouse issued the following statement: 

“Time and time again, Republicans show us their true colors by committing to repeal the ACA and other measures to achieve affordable health care. Trump’s allies in Congress have been trying to destroy the Affordable Care Act and its protections for 135 million Americans with pre-existing conditions for more than a decade. With only 100 days until the election to go, it is apparent that this is a health care election and the contrast could not be clearer. While Democrats deliver lower costs and better care, Republicans reignite their war on health care. Some things never change: Republicans want to gut health care, raising costs, denying and throwing the entire health care system into chaos.

PRESS CALL: U.S. Sen. Debbie Stabenow, Michigan Health Care Advocates to Highlight How the MAGA GOP Health Care Agenda Will Hurt Michiganders

***MEDIA ADVISORY FOR WEDNESDAY, JULY 24, AT 11 A.M.***

Protect Our Care Released New Report on the Threats to Health Care by Donald Trump, Project 2025, and MAGA Republicans

Lansing, Michigan– On Wednesday, July 24, at 11 a.m., U.S. Sen. Debbie Stabenow and Michigan health care advocates will join Protect Our Care Michigan to highlight how the MAGA Republican Party, led by Donald Trump, is escalating their attacks on American health care and doubling down on their plan to deny tens of millions of Americans affordable, lifesaving health care. Speakers will discuss how MAGA Republican lawmakers and their allies continue to threaten to repeal the Affordable Care Act, while also working to dismantle reproductive care, hike premiums, slash Medicare and Medicaid, reverse recent coverage gains, and raise prescription drug costs on Michiganders. On the other hand, the Biden-Harris administration and Congressional Democrats are committed to protecting and strengthening health care by lowering premium costs, extending prescription drug savings to everyone, protecting people with pre-existing conditions, and expanding Medicaid. 

Recent polling from Protect Our Care demonstrates how health care remains a top issue to voters. A large majority – 80 percent of voters – said that the issue of health care will be important to them in voting this year, and the survey revealed overwhelming support for Democrats’ plan to extend the Inflation Reduction Act’s drug pricing reforms. The poll also found that 59 percent of voters agree more with the Biden-Harris Administration and Democrats in Congress on protecting and strengthening the ACA, while fewer voters agree with MAGA Republicans’ efforts to repeal the ACA. 

PRESS CALL:

WHO:
U.S. Sen. Debbie Stabenow
Michigan Rep. Julie Rogers
Erica Shekell, Michigan Planned Parenthood Votes communications director
Linda Vail, former Ingham County health officer
Eric Schneidewind, senior on Medicare and past AARP national president

WHAT: Virtual Press Conference

WHEN: Wednesday, July 24, at 11 a.m.

WHERE: Register for the Zoom event here (Registration required)

STATEMENT: Joe Biden Will Always Be A Health Care Champion

Washington, D.C. — Yesterday, President Joe Biden ended his reelection campaign, endorsing his Vice President, Kamala Harris, for the Democratic Presidential nomination. 

Over the last four years, President Biden has cemented his legacy as a true health care president. Alongside his Vice President Kamala Harris, President Biden capped the cost of insulin at $35 a month for seniors, lowered prescription drug prices, and reduced premiums for people who purchase coverage through the Affordable Care Act. Thanks to their leadership, more people are covered than ever before. The Biden-Harris administration also beat Big Pharma and gave Medicare the power to negotiate lower prices for some of the most expensive drugs on the market, while also protecting Medicaid and Medicare from Republican attacks and strengthening health care for new moms and kids. In addition, President Biden reignited the Cancer Moonshot program to accelerate progress in cancer research and improve the lives of those affected with new programs, policies, and resources.

Both Protect Our Care Executive Director Brad Woodhouse and Chair Leslie Dach issued the following statements: 

“Joe Biden is a health care president,” said Protect Our Care Chair Leslie Dach. “By building on the success of the Affordable Care Act and standing up to greedy drug companies, people across the country now have peace of mind knowing they can afford the lifesaving health care they need. Passing historic legislation like the Inflation Reduction Act made a world of difference for our nation’s seniors, people of color, people with disabilities, rural communities, and countless others. History will remember him as one of the most effective presidents and Protect Our Care will continue to carry on his legacy to ensure everyone, regardless of income, has the health care they need.”

“Joe Biden’s health care legacy is a BFD,” said Protect Our Care Executive Director Brad Woodhouse. “He entered office in the midst of a health care crisis inherited from Donald Trump. From day one, the Biden-Harris administration has been a champion for the middle class, fighting tooth and nail to reverse Trump’s health care sabotage and make affordable health care a reality for seniors and families across the nation. In the face of so many attacks on health care from across the aisle, President Biden doubled down on his efforts to lower drug prices, keep premium costs low, expand Medicaid, and put the health and well-being of families first. Millions of people receive better care at a lower cost thanks to President Biden.”